ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

COVID-19 pill for at-home treatment in trials by Japan's Shionogi

Drug poised to compete with candidates from Roche-owned Chugai and Merck

Commuters in Tokyo: At-home treatments for COVID-19 hold the potential to ease the strain on hospitals. (Photo by Kei Higuchi)
SOSUKE KARINO, Nikkei staff writer | Japan

OSAKA -- Japanese pharmaceutical company Shionogi has begun a Phase 1 trial of an antiviral pill for COVID-19 patients with light symptoms, joining peers worldwide in seeking a therapy to treat infected people at home.

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close